The largest database of trusted experimental protocols

Bronchial tracheal epithelial cell growth kit components

Sourced in United States

The Bronchial/Tracheal Epithelial Cell Growth Kit contains essential components for the culture and growth of bronchial and tracheal epithelial cells. The kit includes basal medium, growth supplements, and other necessary reagents to support the in vitro propagation of these cell types.

Automatically generated - may contain errors

3 protocols using bronchial tracheal epithelial cell growth kit components

1

Cell Culture Protocols for Immune Cell Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human PBMC were isolated from LRS chambers (Stanford Blood Center) and cryopreserved until time of use. CD25+ YT-1 cells (Kuziel et al., 1993 (link)) and PBMC were maintained at 37°C in a 5% CO2 humidified chamber, and cultured in complete RPMI medium (RPMIc) containing 10% FBS and supplemented with 25mM HEPES, 2mM pyruvate, 4mM GlutaMAX, non-essential amino acids, and penicillin-streptomycin (all cell culture reagents were purchased from Gibco). Prior to stimulation for pERK and pAkt studies, cells were starved in serum-free RPMI for 1–2 hours. Primary cells were rested overnight without cytokine before measuring signaling.
Normal human primary bronchial/tracheal epithelial cells were purchased from ATCC (PCS-300–010) and grown in Airway Epithelial Cell Basal Media (ATCC PCS-300–030) supplemented with Bronchial/Tracheal Epithelial Cell Growth Kit components (ATCC PCS300–040) following manufacturer’s instructions. A549 cells were maintained in complete DMEM medium containing 10% FBS and supplemented with 25mM HEPES, 2mM sodium pyruvate, 4mM GlutaMAX, and penicillin-streptomycin. NKL cells were cultured in RPMIc containing 100IU human IL-2, with media and IL-2 changes every other day. All cell lines were maintained at 37°C in a 5% CO2 humidified incubator.
+ Open protocol
+ Expand
2

Culturing Human Lung Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human bronchial epithelial cell line 16HBE was purchased from Millipore (Bedford, MA, United States). Human LUAD cell lines A549 (ATCC CCL-185), NCI-H1975 (ATCC CRL-5908), and NCI-H1299 (ATCC CRL-5803) were acquired from the American Type Culture Collection (Manassas, VA, United States). 16HBE was cultured in Airway Epithelial Cell Basal Media (ATCC) supplemented with Bronchial/Tracheal Epithelial Cell Growth Kit components (ATCC). A549 was cultured in F-12K Medium (Invitrogen, Carlsbad, CA, United States) added with 10% fetal bovine serum (FBS, Invitrogen). NCI-H1975 and NCI-H1299 cells were cultured in RPMI-1640 Medium (Invitrogen) added with 10% FBS. These cells were cultured in 5% CO2 at 37°C. Where indicated, LUAD cells were treated with 200 ng/ml Wnt3a (R&D Systems, Minneapolis, MN, United States) or 25 μM ICG-001 (Selleck, Houston, TX, United States) for the indicated time.
+ Open protocol
+ Expand
3

Human Lung and Monocyte Cell Culture and Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human bronchial epithelial cell 16HBE (Cat. SCC150) was acquired from Merck Millipore (MilliporeSigma, Burlington, MA, USA) and cultured in Airway Epithelial Cell Basal Media (American Type Culture Collection [ATCC], Manassas, VA, USA) supplemented with Bronchial/Tracheal Epithelial Cell Growth Kit components (ATCC). Human LUAD cells A549 (Cat. CCL­185), H1299 (Cat. CRL­5803), H1975 (Cat. CRL­5908), HCC827 (Cat. CRL-2868) and human monocyte line THP-1 (Cat. TIB-202) were obtained from the ATCC and cultured in F­12K (A549) or RPMI­1640 (H1299, H1975, HCC827, and THP-1) media (Invitrogen, Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal bovine serum (FBS; Invitrogen, Thermo Fisher Scientific). All cells were cultured in a humidified incubator at 37 °C and under 5% CO2 . These cells were authenticated by their short tandem repeat (STR) profiles and determined to be mycoplasma free. LUAD cells were treated with 0.2 µg/ml anti-CSF1 antibody (AF216; R&D Systems, Minneapolis, MN, USA) and THP-1 cells were treated with 100 ng/ml phorbol-12-myristate-13-acetate (PMA; Sigma-Aldrich, St. Louis, MO, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!